Cetin, B. And Gumusay, Ö. 2020. Pembrolizumab for Early Triple-Negative Breast Cancer. NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.26 .

Cetin, B., & Gumusay, Ö., (2020). Pembrolizumab for Early Triple-Negative Breast Cancer. NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.26.

Cetin, Bulent, And ÖZGE GÜMÜŞAY. "Pembrolizumab for Early Triple-Negative Breast Cancer," NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.26, 2020

Cetin, Bulent And Gumusay, ÖZGE. "Pembrolizumab for Early Triple-Negative Breast Cancer." NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.26, 2020

Cetin, B. And Gumusay, Ö. (2020) . "Pembrolizumab for Early Triple-Negative Breast Cancer." NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.26.

@article{article, author={Bulent Cetin And author={ÖZGE GÜMÜŞAY}, title={Pembrolizumab for Early Triple-Negative Breast Cancer}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2020}